A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Clinical trial NCT06876649 · RECRUITING

Trial details

NCT number: NCT06876649
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma

Start date: 2025-05-20
Primary completion: 2030-05-01
Enrollment: 787

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.